Roche coaches docs, RNs on diabetes

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetic patients and their caregivers.


Titled "Creative Coaching," the program helps healthcare professionals with "the art of patient engagement," said Luc Vierstraete, SVP and general manager of Roche's US diabetes unit, in a statement.
"A worldwide strategic objective for Roche is to enable diabetes management," said Vierstraete. "We take this very seriously. In the US alone, we have invested more than $14 million in the overall campaign. By locking arms with these dedicated healthcare professionals and providing them with a forum to improve patient self-care, we feel certain this can be achieved."


"What I appreciated most was the purpose of the weekend [program], which was to increase the quality of our healthcare," said Linda Filipi, a California-based registered nurse, in the statement. "For us that means how to become better educators—for Roche, it is how to offer quality products."


Roche manufactures the Accu-Chek line of blood glucose monitors. 
The professional education program, Behavior Change through Patient Engagement, is multifaceted and includes a website with online tools and information, as well as how to effectively integrate Accu-Chek products into their practice.


You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.